| |
| |
|
| Insider
Information: |
Dovey Brian H |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
26 |
|
| Direct
Shares |
22,997 |
|
|
Indirect Shares
|
3,240,409 |
|
|
| Direct
Value |
$7,480 |
|
|
|
Indirect Value
|
$11,603,912 |
|
|
| Total
Shares |
3,263,406 |
|
|
| Total
Value |
$11,611,392 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Align Technology Inc |
ALGN |
Director |
2003-08-08 |
0 |
2003-08-08 |
0 |
Premium* |
|
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-10 |
37,586 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
67,875 |
Premium* |
|
|
Volcano Corp |
VOLC |
10% Owner |
2008-06-03 |
0 |
2008-07-16 |
62,513 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
|
Neose Technologies Inc |
NTEC |
Director |
2009-01-27 |
2,869 |
2007-03-09 |
79,041 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
Director |
2007-11-27 |
20,128 |
2014-04-22 |
129,448 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
|
Otonomy, Inc. |
OTIC |
Director |
2015-05-28 |
0 |
2015-05-28 |
44,460 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2007-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
20,128 |
20,128 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2007-11-27 |
4 |
A |
$0.00 |
$0 |
I/I |
1,963 |
1,963 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2007-11-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(900,000) |
3,543,832 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2008-12-08 |
4 |
B |
$4.47 |
$1,110,397 |
I/I |
248,411 |
4,173 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2008-12-09 |
4 |
B |
$4.93 |
$1,192,518 |
I/I |
241,890 |
8,237 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-07-23 |
4 |
B |
$7.50 |
$4,875,000 |
I/I |
650,000 |
19,138 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-08-11 |
4 |
B |
$7.60 |
$792,680 |
I/I |
104,300 |
20,887 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-08-12 |
4 |
B |
$8.00 |
$3,200,000 |
I/I |
400,000 |
27,595 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-08-13 |
4 |
B |
$7.85 |
$102,050 |
I/I |
13,000 |
27,813 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-08-14 |
4 |
B |
$8.00 |
$209,800 |
I/I |
26,225 |
28,253 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-08-17 |
4 |
B |
$7.64 |
$482,856 |
I/I |
63,201 |
29,313 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-11-10 |
4 |
B |
$6.93 |
$584,892 |
I/I |
84,400 |
30,959 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-11-11 |
4 |
B |
$6.93 |
$371,448 |
I/I |
53,600 |
31,858 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-11-12 |
4 |
B |
$6.90 |
$427,800 |
I/I |
62,000 |
32,898 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-11-20 |
4 |
B |
$6.93 |
$1,732,500 |
I/I |
250,000 |
37,090 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-11-23 |
4 |
B |
$6.93 |
$1,039,500 |
I/I |
150,000 |
39,606 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-11-24 |
4 |
B |
$6.75 |
$337,500 |
I/I |
50,000 |
40,445 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-12-17 |
4 |
B |
$7.55 |
$755,000 |
I/I |
100,000 |
42,122 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2009-12-18 |
4 |
B |
$7.50 |
$285,750 |
I/I |
38,100 |
42,761 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • • |
2011-12-22 |
4 |
B |
$1.45 |
$680,263 |
I/I |
469,147 |
50,643 |
2.25 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2014-04-22 |
4 |
OE |
$0.00 |
$4,691 |
I/I |
4,691,470 |
129,463 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2014-04-22 |
4 |
D |
$5.30 |
$4,696 |
I/I |
(886) |
129,448 |
0 |
- |
|
| OTIC |
Otonomy, Inc. |
Director |
– • – |
2015-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
32,745 |
32,745 |
0 |
- |
|
| OTIC |
Otonomy, Inc. |
Director |
– • – |
2015-05-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(250,000) |
1,329,323 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
157,497 |
|
- |
|
131 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
